These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 17048488)

  • 21. Evaluation of the physicochemical properties and the biocompatibility of polyethylene glycol-conjugated gold nanoparticles: A formulation strategy for siRNA delivery.
    Rahme K; Guo J; Holmes JD; O'Driscoll CM
    Colloids Surf B Biointerfaces; 2015 Nov; 135():604-612. PubMed ID: 26322474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biodegradable polymeric nanocarriers for pulmonary drug delivery.
    Rytting E; Nguyen J; Wang X; Kissel T
    Expert Opin Drug Deliv; 2008 Jun; 5(6):629-39. PubMed ID: 18532919
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biodegradable nanoparticles for drug and gene delivery to cells and tissue.
    Panyam J; Labhasetwar V
    Adv Drug Deliv Rev; 2003 Feb; 55(3):329-47. PubMed ID: 12628320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functionalized STAT1 siRNA nanoparticles regress rheumatoid arthritis in a mouse model.
    Scheinman RI; Trivedi R; Vermillion S; Kompella UB
    Nanomedicine (Lond); 2011 Dec; 6(10):1669-82. PubMed ID: 22087799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of anti-COX2 siRNA coated onto PLGA nanoparticles loading dexamethasone in the treatment of rheumatoid arthritis.
    Park JS; Yang HN; Jeon SY; Woo DG; Kim MS; Park KH
    Biomaterials; 2012 Nov; 33(33):8600-12. PubMed ID: 22910222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells.
    Laquintana V; Denora N; Lopalco A; Lopedota A; Cutrignelli A; Lasorsa FM; Agostino G; Franco M
    Mol Pharm; 2014 Mar; 11(3):859-71. PubMed ID: 24410438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spray drying of siRNA-containing PLGA nanoparticles intended for inhalation.
    Jensen DM; Cun D; Maltesen MJ; Frokjaer S; Nielsen HM; Foged C
    J Control Release; 2010 Feb; 142(1):138-45. PubMed ID: 19840823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation of polyethyleneimine incorporated poly(D,L-lactide-co-glycolide) nanoparticles by spontaneous emulsion diffusion method for small interfering RNA delivery.
    Katas H; Cevher E; Alpar HO
    Int J Pharm; 2009 Mar; 369(1-2):144-54. PubMed ID: 19010405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of preparative variables on small interfering RNA loaded Poly(D,L-lactide-co-glycolide)-chitosan submicron particles prepared by emulsification diffusion method.
    Katas H; Chen S; Osamuyimen AA; Cevher E; Oya Alpar H
    J Microencapsul; 2008 Dec; 25(8):541-8. PubMed ID: 18465303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices.
    Jain RA
    Biomaterials; 2000 Dec; 21(23):2475-90. PubMed ID: 11055295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Colonic gene silencing using siRNA-loaded calcium phosphate/PLGA nanoparticles ameliorates intestinal inflammation in vivo.
    Frede A; Neuhaus B; Klopfleisch R; Walker C; Buer J; Müller W; Epple M; Westendorf AM
    J Control Release; 2016 Jan; 222():86-96. PubMed ID: 26699423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Poly(D,L-lactide-co-glycolide) nanoparticles encapsulated fluorescent isothiocyanate and paclitaxol: preparation, release kinetics and anticancer effect.
    Yang H; Li K; Liu Y; Liu Z; Miyoshi H
    J Nanosci Nanotechnol; 2009 Jan; 9(1):282-7. PubMed ID: 19441308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Co-delivery of SOX9 genes and anti-Cbfa-1 siRNA coated onto PLGA nanoparticles for chondrogenesis of human MSCs.
    Jeon SY; Park JS; Yang HN; Woo DG; Park KH
    Biomaterials; 2012 Jun; 33(17):4413-23. PubMed ID: 22425025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipidoid-polymer hybrid nanoparticles loaded with TNF siRNA suppress inflammation after intra-articular administration in a murine experimental arthritis model.
    Jansen MAA; Klausen LH; Thanki K; Lyngsø J; Skov Pedersen J; Franzyk H; Nielsen HM; van Eden W; Dong M; Broere F; Foged C; Zeng X
    Eur J Pharm Biopharm; 2019 Sep; 142():38-48. PubMed ID: 31199978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Controlled release of anti-inflammatory siRNA from biodegradable polymeric microparticles intended for intra-articular delivery to the temporomandibular joint.
    Mountziaris PM; Sing DC; Chew SA; Tzouanas SN; Lehman ED; Kasper FK; Mikos AG
    Pharm Res; 2011 Jun; 28(6):1370-84. PubMed ID: 21184147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nanoformulation of siRNA silencing Bcl-2 gene and its implication in cancer therapy.
    Jagani HV; Josyula VR; Hariharapura RC; Palanimuthu VR; Gang SS
    Arzneimittelforschung; 2011; 61(10):577-86. PubMed ID: 22164966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PLGA-based nanoparticles as cancer drug delivery systems.
    Sadat Tabatabaei Mirakabad F; Nejati-Koshki K; Akbarzadeh A; Yamchi MR; Milani M; Zarghami N; Zeighamian V; Rahimzadeh A; Alimohammadi S; Hanifehpour Y; Joo SW
    Asian Pac J Cancer Prev; 2014; 15(2):517-35. PubMed ID: 24568455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. siRNA-chitosan complexes in poly(lactic-co-glycolic acid) nanoparticles for the silencing of aquaporin-1 in cancer cells.
    Stigliano C; Aryal S; de Tullio MD; Nicchia GP; Pascazio G; Svelto M; Decuzzi P
    Mol Pharm; 2013 Aug; 10(8):3186-94. PubMed ID: 23789777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostate-targeted biodegradable nanoparticles loaded with androgen receptor silencing constructs eradicate xenograft tumors in mice.
    Yang J; Xie SX; Huang Y; Ling M; Liu J; Ran Y; Wang Y; Thrasher JB; Berkland C; Li B
    Nanomedicine (Lond); 2012 Sep; 7(9):1297-309. PubMed ID: 22583574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Magnetic core-shell nanoparticles for drug delivery by nebulization.
    Verma NK; Crosbie-Staunton K; Satti A; Gallagher S; Ryan KB; Doody T; McAtamney C; MacLoughlin R; Galvin P; Burke CS; Volkov Y; Gun'ko YK
    J Nanobiotechnology; 2013 Jan; 11():1. PubMed ID: 23343139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.